Maximum Recommended Daily Dose of Gabapentin
The maximum recommended dose of gabapentin is 3600 mg/day, divided into three doses (1200 mg three times daily), with doses not exceeding 12 hours apart. 1
Dosing by Indication
For Neuropathic Pain (Postherpetic Neuralgia)
- Maximum dose: 3600 mg/day in three divided doses 1
- Clinical studies demonstrated efficacy from 1800-3600 mg/day, though additional benefit above 1800 mg/day was not consistently demonstrated 1
- The FDA label explicitly states that doses of 3600 mg/day have been administered to patients for relatively short durations and were well tolerated 1
For Epilepsy (Partial Onset Seizures)
- Maximum dose: 3600 mg/day in three divided doses 1
- Dosages up to 2400 mg/day have been well tolerated in long-term clinical studies 1
- Doses of 3600 mg/day have also been administered and well tolerated 1
Important Dosing Considerations
Renal Impairment Adjustments
Dose reduction is mandatory in renal insufficiency 2. For patients with:
- CrCl ≥60 mL/min: 900-3600 mg/day (no adjustment needed)
- CrCl 30-59 mL/min: Maximum 1400 mg/day
- CrCl 15-29 mL/min: Maximum 700 mg/day
- CrCl <15 mL/min: Maximum 300 mg/day 1
Titration Requirements
Gabapentin has nonlinear pharmacokinetics due to saturable absorption, requiring careful titration 2. The guideline evidence recommends:
- Start at 100-300 mg at bedtime or three times daily
- Increase by 100-300 mg every 1-7 days as tolerated
- An adequate trial requires 3-8 weeks for titration plus 2 weeks at maximum dose 2
Clinical Context from Guidelines
The Mayo Clinic neuropathic pain guidelines 2 specify that treatment should be titrated until one of three endpoints is reached:
- Pain relief is achieved
- Dose-limiting adverse effects occur
- 3600 mg/day in 3 divided doses is reached
Common pitfall: The maximum time between doses should not exceed 12 hours 1. This is critical because gabapentin's saturable absorption means that giving larger, less frequent doses reduces bioavailability.
Elderly Patients
Use caution with dose selection in elderly patients due to higher likelihood of decreased renal function; adjust based on creatinine clearance 1.
Practical Reality
While 3600 mg/day is the FDA-approved maximum, real-world data shows that only 22.4% of patients with adequate renal function actually reach the minimum effective dose of 1800 mg/day 3, suggesting significant underdosing in clinical practice. However, higher doses (up to 4800 mg/day) have been suggested in some literature 4 when other antiepileptic drugs have failed, though this exceeds FDA-approved dosing.
The evidence-based maximum remains 3600 mg/day divided into three doses, with mandatory renal dose adjustments.